Never miss a great news story!
Get instant notifications from Economic Times
AllowNot now


You can switch off notifications anytime using browser settings.
11,970.1048.6
Stock Analysis, IPO, Mutual Funds, Bonds & More

Blue chips too can deliver big! Stocks that grew up to 70 times in last 10 years

Royal Enfield manufacturer Eicher Motors has emerged the biggest wealth creator.

, ETMarkets.com|
Updated: Nov 23, 2017, 01.50 PM IST
0Comments
Edelweiss Securities in a research note said the Eicher Motors management has indicated that Royal Enfield’s order intake continues to be higher than billing and average waiting period for Classic 350 is around 1.5-2 months.
Edelweiss Securities in a research note said the Eicher Motors management has indicated that Royal Enfield’s order intake continues to be higher than billing and average waiting period for Classic 350 is around 1.5-2 months.
This is what blue chips can do to your wealth!

Most industry leaders, which are part of equity benchmarks Sensex and Nifty, have given handsome returns to investors over the past 10 years.

Check this: Five companies from the Nifty50 index have swelled investor money up to 70 times in last 10 years since November 2007.

Also Read: This stock doubled investor wealth in one year

Royal Enfield manufacturer Eicher Motors has emerged the biggest wealth creator. An investment of Rs 10,000 in Eicher Motors on November 21, 2007 would have become Rs 6,92,951 on November 21, 2017. That, without taking into account the dividend paid by it through these years.

Eicher stock price jumped from Rs 439 to Rs 30,420 during this period.

Is it worth buying at present levels?

Edelweiss Securities in a research note said the Eicher Motors management has indicated that Royal Enfield’s (RE) order intake continues to be higher than billing and average waiting period for Classic 350 is around 1.5-2 months.

New 650cc twin motorcycles (showcased at EICMA, Milan) — Interceptor and Continental — have been built on an all-new platform. Commercial launch is expected in April 2018 (first across Europe, followed by India), it said.

Edelweiss believes that scale benefits will support margins of the auto firm and maintains a ‘buy’ rating with a target price of Rs 34,945.

The other big gainer on the list is Bajaj Finance. Shares of the NBFC firm converted Rs 10,000 into Rs 5,63,083, as the stock surged from Rs 32.14 on November 21, 2007 to Rs 1,809.75 on November 21, 2017.

IndusInd Bank, Aurobindo Pharma and Asian paints converted an investment of Rs 10,000 into Rs 1,68,569, Rs 1,36,817 and Rs 1,15,499, respectively, in 10 years.

Shares of Maruti Suzuki, BPCL, Lupin, HPCL, YES Bank, HUL, HDFC Bank, HCL Technologies, TCS and Hero MotoCorp swelled five times to turn Rs 10,000 into over Rs 50,000 in last 10 years. Shares of these companies spurted between 400-800 per cent since November 2007.

Arihant Capital Markets in a research report said strong product portfolio and favourable interest rates should benefit Maruti. Uncertainty on foreign exchange and commodity prices is a concern.

“We value the stock at 25.5 times FY19EPS of Rs 340, and assign a price target of Rs 8,670 with a ‘hold’ rating,” it said.

Emkay Global Financial Services has an ‘accumulate’ rating on BPCL with a target price of Rs 529.

Among others, Sun Pharma, UPL, Bosch, UltraTech Cement, ITC, M&M and Dr Reddy’s Labs also multiplied investor wealth by up to four times between November 2007 and now.

JM Financial has a ‘buy’ rating on Sun Pharma with a target price of Rs 590. For Sun Phama, margins seem to have troughed last quarter and are expected to improve going forward. The increasing profitability skew and sensitivity towards more stable branded generics business reduces its earnings volatility. Furthermore, an unchanged topline and margin guidance for FY18 implies a healthy exit run rate.

Regulatory clearance for the Halol facility remains a key near-term catalyst, while acceleration of launch momentum and successful commercialisation of the specialty pipeline will determine medium-to-long term earnings growth trajectory for Sun Pharma, the brokerage said.

Other stocks including Kotak Mahindra Bank, Zee Entertainment, Cipla, HDFC, Tata Motors, IndianOil Corporation, Axis Bank, Infosys, Wipro and GAIL have more than doubled over the past 10 years.

Tech Mahindra grew at a much slower pace, converting Rs 10,000 into just Rs 19,722. Others laggards include Vedanta (Rs 10,000 to Rs 18,819), Ambuja Cement (Rs 10,000 to Rs 17,842), State Bank of India (Rs 10,000 to Rs 16,251) and ICICI Bank (Rs 10,000 to Rs 15,902).

Hindalco, Power Grid, Reliance Industries, Larsen & Toubro and Bharti Airtel also failed to double investor money during the same period.

ONGC, Tata Steel and NPTC were among the top wealth destroyers, having declined 9 per cent, 14 per cent and 24 per cent in last 10 years.

Also Read

Stock market update: 66 stocks hit 52-week lows on NSE

Stock market update: 39 stocks hit 52-week lows on NSE

Stock market update: Realty stocks rise ahead of RBI's policy outcome

Stock market update: 29 stocks hit 52-week lows on NSE

Stock market update: Cement stocks advance; Keerthi Industries jumps 5%

Comments
Add Your Comments
Commenting feature is disabled in your country/region.
Download The Economic Times Business News App for the Latest News in Business, Sensex, Stock Market Updates & More.

Other useful Links


Follow us on


Download et app


Copyright © 2019 Bennett, Coleman & Co. Ltd. All rights reserved. For reprint rights: Times Syndication Service